Literature DB >> 22261817

Transcranial ultrasound from diagnosis to early stroke treatment: part 2: prehospital neurosonography in patients with acute stroke: the Regensburg stroke mobile project.

Felix Schlachetzki1, Moriz Herzberg, Thilo Hölscher, Michael Ertl, Markus Zimmermann, Karl Peter Ittner, Hendrik Pels, Ulrich Bogdahn, Sandra Boy.   

Abstract

BACKGROUND AND
PURPOSE: The primary aim of this study was to investigate the diagnostic accuracy and time frames for neurological and transcranial color-coded sonography (TCCS) assessments in a prehospital '911' emergency stroke situation by using portable duplex ultrasound devices to visualize the bilateral middle cerebral arteries (MCAs).
METHODS: This study was conducted between May 2010 and January 2011. Patients who had sustained strokes in the city of Regensburg and the surrounding area in Bavaria, Germany, were enrolled in the study. After a '911 stroke code' call had been dispatched, stroke neurologists with expertise in ultrasonography rendezvoused with the paramedic team at the site of the emergency. After a brief neurological assessment had been completed, the patients underwent TCCS with optional administration of an ultrasound contrast agent in cases of insufficient temporal bone windows or if the agent had acute therapeutic relevance. The ultrasound studies were performed at the site of the emergency or in the ambulance during patient transport to the admitting hospital. Relevant timelines, such as the time from the stroke alarm to patient arrival at the hospital and the duration of the TCCS, were documented, and positive and negative predictive values for the diagnosis of major MCA occlusion were assessed.
RESULTS: A total of 113 patients were enrolled in the study. MCA occlusion was diagnosed in 10 patients. In 9 of these 10 patients, MCA occlusion could be visualized using contrast-enhanced or non-contrast-enhanced TCCS during patient transport and was later confirmed using computed tomography or magnetic resonance angiography. One MCA occlusion was missed by TCCS and 1 atypical hemorrhage was misdiagnosed. Overall, the sensitivity of a 'field diagnosis' of MCA occlusion was 90% [95% confidence interval (CI) 55.5-99.75%] and the specificity was 98% (95% CI 92.89-99.97%). The positive predictive value was 90% (95% CI 55.5-99.75%) and the negative predictive value was 98% (95% CI 92.89-99.97%). The mean time (standard deviation) from ambulance dispatch to arrival at the patient was 12.3 min (7.09); the mean time for the TCCS examination was 5.6 min (2.2); and the overall mean transport time to the hospital was 53 min (18).
CONCLUSION: Prehospital diagnosis of MCA occlusion in stroke patients is feasible using portable duplex ultrasonography with or without administration of a microbubble contrast agent. Prehospital neurological as well as transcranial vascular assessments during patient transport can be performed by a trained neurologist with high sensitivity and specificity, perhaps opening an additional therapeutic window for sonothrombolysis or neuroprotective strategies.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 22261817     DOI: 10.1159/000334667

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  20 in total

1.  Simultaneous bilateral real-time 3-d transcranial ultrasound imaging at 1 MHz through poor acoustic windows.

Authors:  Brooks D Lindsey; Heather A Nicoletto; Ellen R Bennett; Daniel T Laskowitz; Stephen W Smith
Journal:  Ultrasound Med Biol       Date:  2013-02-13       Impact factor: 2.998

2.  Fast neuroprotection (fast-NPRX) for acute ischemic stroke victims: the time for treatment is now.

Authors:  Paul A Lapchak
Journal:  Transl Stroke Res       Date:  2013-11-07       Impact factor: 6.829

Review 3.  Multimodal brain monitoring in fulminant hepatic failure.

Authors:  Fernando Mendes Paschoal; Ricardo Carvalho Nogueira; Karla De Almeida Lins Ronconi; Marcelo de Lima Oliveira; Manoel Jacobsen Teixeira; Edson Bor-Seng-Shu
Journal:  World J Hepatol       Date:  2016-08-08

4.  3-D transcranial ultrasound imaging with bilateral phase aberration correction of multiple isoplanatic patches: a pilot human study with microbubble contrast enhancement.

Authors:  Brooks D Lindsey; Heather A Nicoletto; Ellen R Bennett; Daniel T Laskowitz; Stephen W Smith
Journal:  Ultrasound Med Biol       Date:  2013-11-14       Impact factor: 2.998

Review 5.  Prehospital stroke care: new prospects for treatment and clinical research.

Authors:  Heinrich J Audebert; Jeffrey L Saver; Sidney Starkman; Kennedy R Lees; Matthias Endres
Journal:  Neurology       Date:  2013-06-28       Impact factor: 9.910

Review 6.  mHealth For Aging China: Opportunities and Challenges.

Authors:  Jing Sun; Yutao Guo; Xiaoning Wang; Qiang Zeng
Journal:  Aging Dis       Date:  2016-01-02       Impact factor: 6.745

7.  Outcomes following sonothrombolysis in severe acute ischemic stroke: subgroup analysis of the CLOTBUST trial.

Authors:  Kristian Barlinn; Georgios Tsivgoulis; Andrew D Barreto; John Alleman; Carlos A Molina; Robert Mikulik; Maher Saqqur; Andrew M Demchuk; Peter D Schellinger; George Howard; Andrei V Alexandrov
Journal:  Int J Stroke       Date:  2014-07-31       Impact factor: 5.266

8.  ROLE OF TRANSCRANIAL COLOUR-CODED DUPLEX SONOGRAPHY IN STROKE MANAGEMENT - REVIEW ARTICLE.

Authors:  Richard B Olatunji; Godwin I Ogbole; Omolola M Atalabi; Abiodun O Adeyinka; Ikeola Lagunju; Alexander Oyinlade; Olufunmilola Ogun; Mayowa O Owolabi; Oluremi A Ogunseyinde; Adesola Ogunniyi
Journal:  West Afr J Ultrasound       Date:  2015

9.  Refraction correction in 3D transcranial ultrasound imaging.

Authors:  Brooks D Lindsey; Stephen W Smith
Journal:  Ultrason Imaging       Date:  2014-01       Impact factor: 1.578

10.  Feasibility of prehospital teleconsultation in acute stroke--a pilot study in clinical routine.

Authors:  Sebastian Bergrath; Arno Reich; Rolf Rossaint; Daniel Rörtgen; Joachim Gerber; Harold Fischermann; Stefan K Beckers; Jörg C Brokmann; Jörg B Schulz; Claas Leber; Christina Fitzner; Max Skorning
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.